Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theodore

Showing results (211-220 of 237) with videos related to

Pageof 24
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2004
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2Nai-Kong V Cheung, Shakeel Modak, Yukang Lin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1994
Long-term results of combined heart-lung transplantation: the Stanford experienceG E Sarris, J A Smith, N E Shumway, et al.
Journal of Neurology|October 20, 2011
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman, Steven L Galetta, Gavin Giovannoni, et al.
The New England Journal of Medicine|September 21, 2012
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosisRobert J Fox, David H Miller, J Theodore Phillips, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 1, 1996
Risk factors for the development of obliterative bronchiolitis after lung transplantationR E Girgis, I Tu, G J Berry, et al.
The Lancet. Neurology|February 10, 2009
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyEva Havrdova, Steven Galetta, Michael Hutchinson, et al.
Nuclear Medicine and Biology|March 12, 2004
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude miceMichael R Lewis, Jiuli Zhang, Fang Jia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 8, 2005
Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion proteinNoriko Sato, Raffit Hassan, Donald B Axworthy, et al.
Annals of Neurology|April 25, 2006
Immune surveillance in multiple sclerosis patients treated with natalizumabOlaf Stüve, Christina M Marra, Keith R Jerome, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM studyMariko Kita, Robert J Fox, J Theodore Phillips, et al.
Pageof 24

Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2004
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2Nai-Kong V Cheung, Shakeel Modak, Yukang Lin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1994
Long-term results of combined heart-lung transplantation: the Stanford experienceG E Sarris, J A Smith, N E Shumway, et al.
Journal of Neurology|October 20, 2011
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman, Steven L Galetta, Gavin Giovannoni, et al.
The New England Journal of Medicine|September 21, 2012
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosisRobert J Fox, David H Miller, J Theodore Phillips, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 1, 1996
Risk factors for the development of obliterative bronchiolitis after lung transplantationR E Girgis, I Tu, G J Berry, et al.
The Lancet. Neurology|February 10, 2009
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyEva Havrdova, Steven Galetta, Michael Hutchinson, et al.
Nuclear Medicine and Biology|March 12, 2004
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude miceMichael R Lewis, Jiuli Zhang, Fang Jia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 8, 2005
Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion proteinNoriko Sato, Raffit Hassan, Donald B Axworthy, et al.
Annals of Neurology|April 25, 2006
Immune surveillance in multiple sclerosis patients treated with natalizumabOlaf Stüve, Christina M Marra, Keith R Jerome, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM studyMariko Kita, Robert J Fox, J Theodore Phillips, et al.
Pageof 24